Job title: Senior Scientist
Bob Liu, PhD, currently Senior Scientist at CytomX Therapeutics, is focusing on target identification and validation for Probody drug conjugates (PDC). He has more than 10 years of experience in the ADC field and has contributed to the development of clinical programs such as EFNA4 and PTK7. His prior industrial experience includes Genentech, Stemcentrx, Cellerant Therapeutics, and Amunix Inc. He obtained his post-doctoral training from Genentech, PhD degree from University of Wisconsin, and Bachelor of Science from University of California-Berkeley.